KRAS and familial pancreatic carcinoma: In 2019, Wang et al., demonstrated that artesunate induced death in KRAS mutant human pancreatic cancer cells (AsPC-1 and PaTU8988) in a ferroptosis manner, preferable to necrosis or apoptosis.